摘要
介绍:自体间充质干细胞(MSCs)的移植已经被证明可以减轻几种动物模型的肾损伤和功能障碍,而且目前它的疗效正在对肾病患者进行临床试验测试。越来越多的证据表明,MSCs释放出细胞囊泡(EVs),将基因、microRNAs和蛋白质传递给受体细胞,作为MSC旁分泌作用的介质。在此背景下,对MSC-衍生出的EV货物进行描述,以阐明其对肾脏修复的潜在贡献是至关重要的。近年来,研究人员进行了高通量测序和蛋白质组分析,以检测和识别MSC衍生的EVs中丰富的基因、microRNAs和蛋白质。 总结:本综述总结了MSC衍生的EV分泌物的现有知识,以揭示介入MSC肾脏修复的机制,并讨论了临床前和临床研究,测试了MSC衍生的EVs治疗肾病的疗效。
关键词: 外泌体,细胞外囊泡,肾,间充质干细胞,microRNA,外周血微泡
Current Gene Therapy
Title:Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair
Volume: 17 Issue: 1
关键词: 外泌体,细胞外囊泡,肾,间充质干细胞,microRNA,外周血微泡
摘要: Introduction: Transplantation of autologous mesenchymal stem cells (MSCs) has been shown to attenuate renal injury and dysfunction in several animal models, and its efficacy is currently being tested in clinical trials for patients with renal disease. Accumulating evidence indicates that MSCs release extracellular vesicles (EVs) that deliver genes, microRNAs and proteins to recipient cells, acting as mediators of MSC paracrine actions. In this context, it is critical to characterize the MSC-derived EV cargo to elucidate their potential contribution to renal repair. In recent years, researchers have performed high-throughput sequencing and proteomic analysis to detect and identify genes, microRNAs, and proteins enriched in MSC-derived EVs.
Conclusion: The present review summarizes the current knowledge of the MSC-derived EV secretome to shed light into the mechanisms mediating MSC renal repair, and discusses preclinical and clinical studies testing the efficacy of MSC-derived EVs for treating renal disease.Export Options
About this article
Cite this article as:
Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair, Current Gene Therapy 2017; 17 (1) . https://dx.doi.org/10.2174/1566523217666170412110724
DOI https://dx.doi.org/10.2174/1566523217666170412110724 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria
Current Diabetes Reviews Epidural Labour Analgesia and Labour Outcome
Current Women`s Health Reviews Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry New Drugs for Epidural Analgesia
Current Drug Targets Molecular Function of Tocopherols in Age Related Diseases
Current Pharmaceutical Design Adverse Drug Reactions Amongst Adult Patients Admitted in Lagos State University Teaching Hospital Lagos, Nigeria
Current Drug Safety Pediatric Chronic Daily Headache
Current Pediatric Reviews Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Recent Progress in the Analysis of Captopril Using Electrochemical Methods: A Review
Current Analytical Chemistry Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Combinations of Renin-Angiotensin-Aldosterone System Antagonists:True Advantages?
Current Pharmaceutical Design Membrane Transporters in Physiological Barriers of Pharmacological Importance
Current Pharmaceutical Design Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Current Drug Targets - Cardiovascular & Hematological Disorders Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer
Current Cancer Drug Targets Endocannabinoid Metabolic Pathways and Enzymes
Current Drug Targets - CNS & Neurological Disorders Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis
Current Cardiology Reviews The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics
Current Pharmaceutical Design Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
Current Pharmaceutical Design Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers